Kiminori Kimura, MD
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (NCT07681089) | Kiminori Kimura, MD | 2026-09-01 |
| A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201) (NCT06144086) | Kiminori Kimura, MD | 2024-05-08 |
| Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia. (NCT04688034) | Kiminori Kimura, MD | 2021-03-15 |
| Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I) (NCT04047160) | Kiminori Kimura, MD | 2019-08-29 |
| Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis (NCT03620474) | Kiminori Kimura, MD | 2018-07-24 |
Track Kiminori Kimura, MD automatically
Every clearance here is in the API, with alerts when new ones post.